SUSAN WHITE-DRAGON: Open Payments
NPI 1295358760 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 16 payments from 9 companies in 2025. Trend: 2023 $218 · 2024 $204 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| ABBVIE INC. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Amgen Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, QULIPTA, Rybelsus, KRYSTEXXA, CAPVAXIVE, Wegovy, AIRSUPRA, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
